Aged 18 years or older
Previously taken one or more statins
Withdrawn from statins because of perceived side effects
Developed side effects within 2 weeks of initiation
Clinical indication for statins for primary or secondary prevention of cardiovascular disease or dyslipidaemia, on either no medication or non-statin lipid lowering therapy (e.g, ezetimibe)

NCT02668016_inc_T1
Person
Aged
NCT02668016_inc_T2
Value
18 years or older
NCT02668016_inc_T3
Multiplier
one or more
NCT02668016_inc_T4
Drug
statins
NCT02668016_inc_T6
Condition
side effects
NCT02668016_inc_T7
Temporal
within 2 weeks of initiation
NCT02668016_inc_T8
Reference_point
initiation
NCT02668016_inc_T9
Condition
indication
NCT02668016_inc_T10
Drug
statins
NCT02668016_inc_T11
Observation
prevention of cardiovascular disease
NCT02668016_inc_T12
Qualifier
secondary
NCT02668016_inc_T13
Qualifier
primary
NCT02668016_inc_T14
Condition
dyslipidaemia
NCT02668016_inc_T15
Scope
primary or secondary
NCT02668016_inc_T16
Scope
primary or secondary prevention of cardiovascular disease or dyslipidaemia